RT Book, Section
A1 Panus, Peter C.
A1 Jobst, Erin E.
A1 Masters, Susan B.
A1 Katzung, Bertram
A1 Tinsley, Suzanne L.
A1 Trevor, Anthony J.
SR Print(0)
ID 6090666
T1 Chapter 6. Sympathomimetics and Sympatholytics
T2 Pharmacology for the Physical Therapist
YR 2009
FD 2009
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-146043-9
LK accessphysiotherapy.mhmedical.com/content.aspx?aid=6090666
RD 2024/04/23
AB Receptors  of  the  sympathetic  system  may  be  divided  into  alpha  (α),  beta  (β),  and  dopamine  (D)  receptors.  Drugs  that  bind  to  these  receptors  and  modulate  or  mimic  the  function  of  the  sympathetic  nervous  system  may  be  divided  into  those  which  augment  the  system  (sympathomimetics)  and  those  which  antagonize  the  system  (sympatholytics).  The  sympathomimetics  constitute  a  very  important  group  of  agonists  used  for  cardiovascular,  respiratory,  and  other  conditions.  They  are  readily  divided  into  subgroups  on  the  basis  of  their  spectrum  of  affinity  for  α,  β,  or  D  receptors.  Alternatively,  sympathomimetics  may  be  divided  into  subgroups  based  on  whether  their  mode  of  action  is  direct  or  indirect.  Sympatholytics  are  an  important  group  of  antagonists  used  in  cardiovascular  and  other  conditions.  These  drugs  are  divided  into  primary  subgroups  on  the  basis  of  their  receptor  (α  and  β)  selectivity.